Q1 2020 Holdings
Filed 2020-05-15 | 110 holdings | $4.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.8B | 41,904,586 | 38.5% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.4B | 11,777,285 | 31.5% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $641.3M | 7,589,294 | 13.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $381.8M | 3,390,270 | 8.3% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $134.3M | 1,019,557 | 2.9% |
| Cerus Corporation(CERS) | COM | 157085101 | $63.8M | 13,713,195 | 1.4% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $52.3M | 889,757 | 1.1% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $24.7M | 1,701,929 | 0.5% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $21.9M | 10,946,166 | 0.5% |
| Adaptive Biotechnologies Corporation(ADPT) | COM | 00650F109 | $20.7M | 743,734 | 0.4% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $10.0M | 3,690,307 | 0.2% |
| Alector, Inc.(ALEC) | COM | 014442107 | $6.8M | 280,000 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $5.8M | 50,060,240 | 0.1% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $4.6M | 636,363 | 0.1% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $4.1M | 1,060,714 | 0.1% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $2.6M | 175,000 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.3M | 31,978,785 | 0.1% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $1.7M | 121,534 | 0.0% |
| Autolus Therapeutics plc(AUTL) | SPON ADS | 05280R100 | $939.0K | 156,773 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $786.6K | 8,760,794 | 0.0% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $552.1K | 11,574,538 | 0.0% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $176.5K | 3,144,000 | 0.0% |
| CytomX Therapeutics, Inc.(CTMX) | COM | 23284F105 | $153.0K | 20,000 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR | 023111206 | $138.0K | 34,496,685 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $124.4K | 9,100,615 | 0.0% |
| Principia Biopharma Inc.(PRNB) | COM | 74257L108 | $116.1K | 1,955,413 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $108.4K | 1,409,784 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $107.3K | 1,240,243 | 0.0% |
| Exact Sciences Corporation(EXAS) | COM | 30063P105 | $107.1K | 1,846,139 | 0.0% |
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | $100.5K | 2,093,839 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $100.1K | 1,499,212 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $83.2K | 1,774,234 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $70.7K | 6,018,104 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $60.6K | 1,708,472 | 0.0% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $58.7K | 2,666,015 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A COM | 04965G109 | $58.5K | 3,532,760 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $57.3K | 14,614,264 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $48.5K | 3,025,384 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $43.3K | 2,799,577 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $41.2K | 2,708,200 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $40.9K | 946,471 | 0.0% |
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $39.3K | $30,770,000 | 0.0% |
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $38.7K | 3,397,740 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | COM | 16383L106 | $34.5K | 859,015 | 0.0% |
| Allakos Inc.(ALLKGUSD) | COM | 01671P100 | $32.7K | 735,469 | 0.0% |
| GW Pharmaceuticals plc | ADS | 36197T103 | $32.5K | 370,845 | 0.0% |
| Merus N.V. | COM | N5749R100 | $24.7K | 2,037,469 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | COM | 03753U106 | $24.0K | 896,551 | 0.0% |
| Assembly Biosciences, Inc. | COM | 045396108 | $22.9K | 1,541,618 | 0.0% |
| Frequency Therapeutics, Inc. | COM | 35803L108 | $21.0K | 1,180,162 | 0.0% |